VoxCell BioInnovation

Not another bioprinting company. VoxCell BioInnovation is redefining tissue engineering for the drug development industry. We specialize in creating an extraordinary line of vascularized human-like cancer tissue models, enabling pharmaceutical companies to identify unviable drug candidates earlier in the development process. Operating as a screening platform without FDA approval, we accelerate therapy development, ensuring life-saving treatments reach those in need faster

Bioprinting,bioink,tissue engineering,biotechnology,3d bioprinting,biopharma,drug development,vascularization,3d printing,cancer,personalized medicine,oncology,research,pre-clinical,and tissue models

Voxcell bioinnovation operates in the Biotechnology research industry.

Voxcell bioinnovation's revenue is 11m - 100m

Voxcell bioinnovation has 11 - 50 employees.